Last updated on November 2017

A Multi-Center, Randomized, Double-Blind, And Placebo-Controlled Phase II Clinical Study To Investigate The Safety And Efficacy Of Two Doses Of KT07 Compared To Placebo In Subjects With Acute Uncomplicated Influenza.


Brief description of study

A Multi-Center, Randomized, Double-Blind, And Placebo-Controlled Phase II Clinical Study To Investigate The Safety And Efficacy Of Two Doses Of KT07 Compared To Placebo In Subjects With Acute Uncomplicated Influenza.

Detailed Study Description

This is a Phase II, Randomized, Double-Blind, And Placebo-Controlled. To investigate clinical efficacy of KT07 capsule in alleviation of fever and other symptoms including nasal congestion, sore throat, cough,aches and pains, fatigue, headache, chills or sweats in subjects with acute uncomplicated influenza.

Clinical Study Identifier: TX9479

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Carlos M. Manzano

AppleMed Research Group, LLC
Miami, FL USA
  Connect »